Robert B. Bazemore
Chief Operating Officer, SYNAGEVA BIOPHARMA CORP.
Companies
- Akari Therapeutics PlcBoard member Sep 18, 2024 to now1
- Nuvation Bio Inc.Board member Feb 12, 2021 to now2
- Ardelyx (United States)Board member Jun 6, 2016 to now3
- Epizyme, Inc.Board member Sep 14, 2015 to Mar 29, 20214
- Epizyme, Inc.Chief executive officer Sep 14, 2015 to Mar 29, 20214
- Epizyme, Inc.President Sep 14, 2015 to Mar 29, 20214
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Akari Therapeutics Plc AKTX44,642 shares5$373.7K at $8.37Mar 24, 2025
- Ardelyx (United States) ARDX68,006 shares6$210.8K at $3.10Jun 16, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 16, 2026Granted 26,455 shares of Ardelyx (United States)6
- Jun 18, 2025Granted 41,551 shares of Ardelyx (United States)7
- Mar 6, 2025Granted 44,642 shares at $1.12 of Akari Therapeutics Plc8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAkari Therapeutics Plc, Board member
- 2SEC EDGARNuvation Bio Inc., Board member
- 3
- 4SEC EDGAREpizyme, Inc., Board member
- 5
- 6
- 7SEC EDGARForm 4 filed Jun 23, 2025
- 8SEC EDGARForm 4 filed Mar 10, 2025